{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:17:49Z","timestamp":1790360269383,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.autrev.2017.12.006","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T19:04:44Z","timestamp":1523041484000},"page":"567-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":270,"title":["Beh\u00e7et's disease: New insights into pathophysiology, clinical features and treatment options"],"prefix":"10.1016","volume":"17","author":[{"given":"Antonio","family":"Greco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"De Virgilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Ralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ciofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Attanasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"de Vincentiis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lambiase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.12.006_bb0005","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.12.006_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bjo.40.6.355","article-title":"Description of Beh\u00e7et's syndrome in the Hippocratic third book of endemic diseases","volume":"40","author":"Feigenbaum","year":"1956","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0714.1978.tb01601.x","article-title":"Etiology, pathogenesis and classification of aphthous stomatitis and Beh\u00e7et's syndrome","volume":"7","author":"Cohen","year":"1978","journal-title":"J Oral Pathol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.euje.2006.12.007","article-title":"The migration pattern, patient selection with diagnostic methodological flaw and confusing naming dilemma in Beh\u00e7et disease","volume":"8","author":"Evereklioglu","year":"2007","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.autrev.2017.12.006_bb0025","first-page":"471","article-title":"Benediktos Adamantiades and his forgotten contributions to medicine","volume":"12","author":"Zouboulis","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0030","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/ard.62.7.691","article-title":"Early descriptions of Adamantiades-Beh\u00e7et's disease","volume":"62","author":"Zouboulis","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.006_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","article-title":"Beh\u00e7et syndrome: a contemporary review","volume":"14","author":"Yazici","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2017.12.006_bb0040","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1378\/chest.120.6.2116","article-title":"Some more historical notes on Adamantiades-Beh\u00e7et's disease","volume":"120","author":"Tirilomis","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2017.12.006_bb0045","first-page":"1152","article-title":"Uber rezidivierende, aphthose, durch ein virus verursachte Geschw\u00fcre am Mund, am Auge und an den Genitalien","volume":"105","author":"Beh\u00e7et","year":"1937","journal-title":"Dermatol Wochenschr"},{"key":"10.1016\/j.autrev.2017.12.006_bb0050","first-page":"420","article-title":"Considerations sur les lesions aphteuses de la bouche et des parties genitals, ainsi que sur les manifestations oculaires d'origine probablement virutique et observations concernant leur foyer d'infection","volume":"45","author":"Beh\u00e7et","year":"1938","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"10.1016\/j.autrev.2017.12.006_bb0055","first-page":"1222","article-title":"Einige Bemerkungen zu meinen Beobachtungen \u00fcber den Tri- Symptomenkomplex","volume":"35","author":"Beh\u00e7et","year":"1939","journal-title":"Med Welt"},{"key":"10.1016\/j.autrev.2017.12.006_bb0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000253787","article-title":"Some observations on the clinical picture of the so-called triple symptom complex","volume":"81","author":"Beh\u00e7et","year":"1940","journal-title":"Dermatologica"},{"key":"10.1016\/j.autrev.2017.12.006_bb0065","first-page":"512","article-title":"History and development of Beh\u00e7et's disease","volume":"63","author":"Dilsen","year":"1996","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1016\/j.autrev.2017.12.006_bb0070","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","article-title":"Beh\u00e7et's disease-a contemporary review","volume":"32","author":"Mendes","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.12.006_bb0075","series-title":"Beh\u00e7et's disease: proceedings of the sixth international conference on Beh\u00e7et's disease, held in Paries, France, June 30 to July 1, 1993","first-page":"295","article-title":"Pseudo-Beh\u00e7et's syndrome-a description of twenty-three cases","author":"Levine","year":"1993"},{"key":"10.1016\/j.autrev.2017.12.006_bb0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","article-title":"Beh\u00e7et's disease, the silk road and HLA-B51: historical and geographical perspectives","volume":"54","author":"Verity","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.autrev.2017.12.006_bb0085","first-page":"1","article-title":"Beh\u00e7et's disease physiopathology: a contemporary review","volume":"7","author":"Zeidan","year":"2016","journal-title":"Auto Immun Highlights"},{"key":"10.1016\/j.autrev.2017.12.006_bb0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3349\/ymj.2012.53.1.35","article-title":"New insights in the clinical understanding of Beh\u00e7et's disease","volume":"53","author":"Cho","year":"2012","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.autrev.2017.12.006_bb0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1756-185X.2010.01549.x","article-title":"Beh\u00e7et's disease in Iran: analysis of 6500 cases","volume":"13","author":"Davatchi","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.006_bb0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/BOR.0000000000000349","article-title":"Beh\u00e7et's syndrome in nonendemic regions","volume":"29","author":"Leccese","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/IIO.0b013e3181d2e030","article-title":"Beh\u00e7et disease in the developing world","volume":"50","author":"Tugal-Tutkun","year":"2010","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.autrev.2017.12.006_bb0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7861\/clinmedicine.17-1-71","article-title":"Beh\u00e7et's disease","volume":"17","author":"Nair","year":"2017","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.autrev.2017.12.006_bb0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1525-1470.1994.tb00559.x","article-title":"Clinical analysis of 40 cases of childhood-onset Beh\u00e7et's disease","volume":"11","author":"Kim","year":"1994","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0120","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00417-010-1399-5","article-title":"Late-onset Beh\u00e7et's disease: demographic, clinical, and ocular features","volume":"248","author":"Sungur","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0125","series-title":"Beh\u00e7et's disease: a guide to its clinical understanding","author":"Lee","year":"2001"},{"key":"10.1016\/j.autrev.2017.12.006_bb0130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11926-010-0132-z","article-title":"Beh\u00e7et's syndrome","volume":"12","author":"Yazici","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2017.12.006_bb0135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3346\/jkms.2003.18.2.231","article-title":"Influence of sex on patients with Beh\u00e7et's disease in Korea","volume":"18","author":"Bang","year":"2003","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2017.12.006_bb0140","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.biopha.2017.04.106","article-title":"Epigenetic alterations in chronic disease focusing on Beh\u00e7et disease: Review","volume":"91","author":"Alipour","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.autrev.2017.12.006_bb0145","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00296-007-0367-9","article-title":"Pro-inflammatory cellular immune response in Beh\u00e7et's disease","volume":"27","author":"Kulaber","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2017.12.006_bb0150","doi-asserted-by":"crossref","DOI":"10.1007\/s40744-018-0100-z","article-title":"Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases","author":"Bodis","year":"2018","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.autrev.2017.12.006_bb0155","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.berh.2004.02.008","article-title":"Beh\u00e7et's disease","volume":"18","author":"Marshall","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/BOR.0000000000000234","article-title":"Genetics of Beh\u00e7et's disease","volume":"28","author":"Morton","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2133.2007.08403.x","article-title":"Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Beh\u00e7et's disease","volume":"158","author":"Lew","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0170","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3109\/14653249.2011.571245","article-title":"CD4(+) CD25(+) regulatory T cells ameliorate Beh\u00e7et's disease-like symptoms in a mouse model","volume":"13","author":"Shim","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.autrev.2017.12.006_bb0175","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.autrev.2012.11.001","article-title":"Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Beh\u00e7et's disease: a systematic review and meta-analysis","volume":"12","author":"Chamorro","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.006_bb0180","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3349\/ymj.1997.38.6.411","article-title":"Epidemiological features of Adamantiades-Beh\u00e7et's disease in Germany and in Europe","volume":"38","author":"Zouboulis","year":"1997","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.autrev.2017.12.006_bb0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/08830189709116842","article-title":"The role of heat shock protein, microbial and autoimmune agents in the aetiology of Beh\u00e7et's disease","volume":"14","author":"Lehner","year":"1997","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0190","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/ard.60.11.996","article-title":"Beh\u00e7et's disease: infectious aetiology, new autoantigens, and HLA-B51","volume":"60","author":"Direskeneli","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.006_bb0195","first-page":"s27","article-title":"The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Beh\u00e7et's disease","author":"Mumcu","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0200","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02505221","article-title":"Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Beh\u00e7et's disease","volume":"288","author":"Lee","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2017.12.006_bb0205","first-page":"21","article-title":"Beh\u00e7et's disease-like symptoms induced by the Herpes simplex virus in ICR mice","volume":"8","author":"Sohn","year":"1998","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0210","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1365-2133.2001.04498.x","article-title":"Experimental studies on the antiviral agent famciclovir in Beh\u00e7et's disease symptoms in ICR mice","volume":"145","author":"Sohn","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0215","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1067\/mjd.2001.117728","article-title":"HSP 60 expression in mucocutaneous lesions of Beh\u00e7et's disease","volume":"45","author":"Ergun","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.autrev.2009.10.005","article-title":"Etiopathogenesis of Beh\u00e7et's disease","volume":"9","author":"Mendoza-Pinto","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.006_bb0225","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.11074","article-title":"Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Beh\u00e7et's disease","volume":"48","author":"Lee","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.006_bb0230","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2011.12.005","article-title":"Beh\u00e7et's disease","volume":"11","author":"Zhou","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.006_bb0235","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","article-title":"New insights into the pathogenesis of Beh\u00e7et's disease","volume":"11","author":"Pineton de Chambrun","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.006_bb0240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1601-0825.2005.01185.x","article-title":"Diversity of gammadelta T cells in patients with Beh\u00e7et's disease is indicative of polyclonal activation","volume":"12","author":"Freysdottir","year":"2006","journal-title":"Oral Dis"},{"key":"10.1016\/j.autrev.2017.12.006_bb0245","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/0-306-48382-3_53","article-title":"T-gammadelta receptor restriction in peripheral lymphocytes of patients with Beh\u00e7et's disease","volume":"528","author":"van Hagen","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0250","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1067\/mlc.2003.1","article-title":"Expansion of gd T-cells in Beh\u00e7et's disease: role of disease activity and microbial flora in oral ulcers","volume":"141","author":"Bank","year":"2003","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.autrev.2017.12.006_bb0255","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(96)90868-5","article-title":"Role of gd T cells in pathogenesis and diagnosis of Beh\u00e7et's disease","volume":"347","author":"Hasan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.12.006_bb0260","first-page":"2301","article-title":"Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Beh\u00e7et's disease","volume":"21","author":"Hamzaoui","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0265","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/ar3005","article-title":"Natural killer cells control a T-helper 1 response in patients with Beh\u00e7et's disease","volume":"12","author":"Yamaguchi","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.12.006_bb0270","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/08820139.2017.1288240","article-title":"Natural Killer Cell Subsets and Their Functional Activity in Beh\u00e7et's Disease","volume":"46","author":"Cosan","year":"2017","journal-title":"Immunol Invest"},{"key":"10.1016\/j.autrev.2017.12.006_bb0275","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-4632.2009.03905.x","article-title":"Significance of serum interleukin-8 levels in patients with Beh\u00e7et's disease: high levels may indicate vascular involvement","volume":"48","author":"Durmazlar","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0280","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2249.2005.02695.x","article-title":"Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Beh\u00e7et's disease","volume":"139","author":"Imamura","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0285","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/art.20334","article-title":"Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Beh\u00e7et's disease","volume":"50","author":"Ben Ahmed","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.006_bb0290","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3129\/i07-179","article-title":"Th1 polarization of the immune response in uveitis in Beh\u00e7et's disease","volume":"43","author":"Ilhan","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0295","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/03009740600905380","article-title":"Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Beh\u00e7et's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD","volume":"35","author":"Dalghous","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0300","first-page":"S27","article-title":"A Th1 but not a Th17 response is present in the gastrointestinal involvement of Beh\u00e7et's disease","volume":"28","author":"Ferrante","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0305","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-018-4049-7","article-title":"Correlation between IL-17A\/F, IL-23, IL-35 and IL-12\/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Beh\u00e7et's patients","author":"Sonmez","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0310","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaci.2011.07.008","article-title":"Regulation of T(H)17 and regulatory T cells in patients with Beh\u00e7et disease","volume":"128","author":"Direskeneli","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0315","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/icb.2010.137","article-title":"Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns","volume":"89","author":"Miyara","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0320","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2017.12.006_bb0325","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/jid.2010.114","article-title":"IL-17A has an important role in the acute attacks of Beh\u00e7et's disease","volume":"130","author":"Ekinci","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0330","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2559.2000.00859.x","article-title":"Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Beh\u00e7et disease","volume":"36","author":"Kobayashi","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.autrev.2017.12.006_bb0335","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2559.2004.01954.x","article-title":"Neutrophilic phlebitis is characteristic of intestinal Beh\u00e7et's disease and simple ulcer syndrome","volume":"45","author":"Hayasaki","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.autrev.2017.12.006_bb0340","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/1744666X.2016.1205486","article-title":"Beh\u00e7et's disease: epidemiology, clinical manifestations, and diagnosis","volume":"13","author":"Davatchi","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0345","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease","volume":"335","author":"International Study Group for Beh\u00e7et's Disease","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.12.006_bb0350","first-page":"581468","article-title":"A new Diagnostic Way for Beh\u00e7et's Disease: Skin Prick with Self Saliva","author":"Kaneko","year":"2014","journal-title":"Genet Res Int"},{"key":"10.1016\/j.autrev.2017.12.006_bb0355","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MD.0b013e3182428126","article-title":"Long-term outcome of arterial lesions in Beh\u00e7et disease: a series of 101 patients","volume":"91","author":"Saadoun","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.12.006_bb0360","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0b013e3283410088","article-title":"Major vessel involvement in Beh\u00e7et's disease: an update","volume":"23","author":"Calamia","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0365","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.berh.2016.08.002","article-title":"Beh\u00e7et's disease: How to diagnose and treat vascular involvement","volume":"30","author":"Seyahi","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0370","first-page":"542","article-title":"Cardiovascular manifestations of Beh\u00e7et's disease","volume":"150","author":"Wechsler","year":"1999","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.autrev.2017.12.006_bb0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MD.0b013e3182428f49","article-title":"Spectrum of cardiac lesions in behcet disease: a series of 52 patients and review of the literature","volume":"91","author":"Geri","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.12.006_bb0380","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Beh\u00e7et's disease: evaluation of 200 patients, the Neuro-Beh\u00e7et Study Group","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2017.12.006_bb0385","first-page":"926","article-title":"Neurological manifestations of Beh\u00e7et's disease","volume":"158","author":"Wechsler","year":"2002","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.autrev.2017.12.006_bb0390","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.autrev.2012.05.008","article-title":"Bell's palsy and autoimmunity","volume":"12","author":"Greco","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.006_bb0395","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.rdc.2017.09.007","article-title":"Gastrointestinal involvement in Beh\u00e7et's Disease","volume":"44","author":"Hatemi","year":"2018","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.autrev.2017.12.006_bb0400","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.autrev.2011.05.005","article-title":"Sudden sensorineural hearing loss: an autoimmune disease?","volume":"10","author":"Greco","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.006_bb0405","first-page":"2579","article-title":"La meningo-encephalite de la maladie de Beh\u00e7et","volume":"69","author":"Alajouanine","year":"1961","journal-title":"Presse Med"},{"key":"10.1016\/j.autrev.2017.12.006_bb0410","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/000348949110000607","article-title":"Effect of cyclosporine A on the hearing loss in Beh\u00e7et's disease","volume":"100","author":"Elidan","year":"1991","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0415","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.heares.2004.11.020","article-title":"K. balci, E. Koseoglu, I. Yuce, S. Cagli, M. Senturk, Audio-vestibular disturbances in Beh\u00e7et's patients: report of 62 cases","volume":"203","author":"Kulahli","year":"2005","journal-title":"Hear Res"},{"key":"10.1016\/j.autrev.2017.12.006_bb0420","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0030-4220(91)90185-F","article-title":"Clinical features of Beh\u00e7et's disesase: a report of four cases","volume":"72","author":"Helm","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0425","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2230.2006.02284.x","article-title":"Pathergy reaction in different body areas in Beh\u00e7et's disease","volume":"32","author":"Ozdemir","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0430","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","article-title":"Current concepts in the etiology and treatment of Beh\u00e7ets disease","volume":"50","author":"Evereklioglu","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0435","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/ard.52.8.619","article-title":"Effect of surgical clearing of the skin on the pathergy phenomenon in Beh\u00e7et's syndrome","volume":"52","author":"Fresco","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.12.006_bb0440","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.autrev.2013.01.004","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"12","author":"Greco","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.006_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JMDH.S150940","article-title":"Optimal management of Cogan's syndrome: a multidisciplinary approach","volume":"11","author":"D'Aguanno","year":"2017","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.autrev.2017.12.006_bb0450","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.autrev.2014.04.004","article-title":"Susac's syndrome - pathogenesis, clinical variants and treatment approaches","volume":"13","author":"Greco","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.006_bb0455","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3109\/14992027.2012.705904","article-title":"Sudden sensorineural hearing loss: a vascular cause? Analysis of prothrombotic risk factors in head and neck","volume":"51","author":"Fusconi","year":"2012","journal-title":"Int J Audiol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0460","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.autrev.2012.01.004","article-title":"Meniere's disease might be an autoimmune condition?","volume":"11","author":"Greco","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.006_bb0465","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3129\/i08-080","article-title":"Beh\u00e7et's disease: comparing 3 decades of treatment response at the National Eye Institute","volume":"43","author":"Kump","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0470","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2003.07.018","article-title":"Comparison of patients with Beh\u00e7et's disease in the 1980s and 1990s","volume":"111","author":"Yoshida","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.autrev.2017.12.006_bb0475","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-3476(98)70368-3","article-title":"Clinical features of Beh\u00e7et's disease in children: an international collaborative study of 86 cases","volume":"132","author":"Kon\u00e9-Paut","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2017.12.006_bb0480","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Beh\u00e7et syndrome A 2-decade outcome survey of 387 patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.12.006_bb0485","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"New Engl J Med"},{"key":"10.1016\/j.autrev.2017.12.006_bb0490","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/s10165-009-0200-2","article-title":"Colchicine versus placebo in Beh\u00e7et's disease: randomized, double-blind, controlled crossover trial","volume":"19","author":"Davatchi","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0495","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/rheumatology\/keh311","article-title":"Influence of human recombinant interferon-a2a (rhIFN-a2a) on altered lymphocyte subpopulations and monocytes in Beh\u00e7et's disease","volume":"43","author":"Treusch","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2017.12.006_bb0500","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.bor.0000197995.27579.9b","article-title":"New approaches in the treatment of Adamantiades-Beh\u00e7et's disease","volume":"18","author":"Pipitone","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0505","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0753-3322(01)00154-8","article-title":"Thalidomide in Beh\u00e7et's disease","volume":"56","author":"Shek","year":"2002","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.autrev.2017.12.006_bb0510","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et syndrome. A randomized, double-blind, placebo controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2017.12.006_bb0515","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MD.0b013e3181dfca14","article-title":"Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysis","volume":"89","author":"Hello","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.12.006_bb0520","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10238-004-0033-4","article-title":"Beh\u00e7et's disease","volume":"4","author":"Suzuki Kurokawa","year":"2004","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.autrev.2017.12.006_bb0525","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.autrev.2014.01.056","article-title":"Biotherapies in Beh\u00e7et's disease","volume":"13","author":"Comarmond","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.12.006_bb0530","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/BOR.0000000000000497","article-title":"Management of Beh\u00e7et's disease","volume":"30","author":"Alibaz-Oner","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0535","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","article-title":"Anti-TNF agents for Beh\u00e7et's disease: analysis of published data on 369 patients","volume":"41","author":"Arida","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.12.006_bb0540","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10384-006-0425-y","article-title":"Infliximab treatment for ocular and extraocular manifestations of Beh\u00e7et's disease","volume":"51","author":"Accorinti","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0545","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bjo.2003.037192","article-title":"Anti-TNF-alpha therapy for sight threatening uveitis","volume":"89","author":"Lindstedt","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0550","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1196\/annals.1423.050","article-title":"Anti-TNF-alpha therapy in seven patients with Beh\u00e7et's uveitis: advantages and controversial aspects","volume":"1110","author":"Tognon","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2017.12.006_bb0555","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7326\/0003-4819-140-5-200403020-00025","article-title":"Infliximab for recurrent, sight threatening ocular inflammation in Adamantiades\u2013Beh\u00e7et disease","volume":"140","author":"Sfikakis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2017.12.006_bb0560","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1186\/ar3043","article-title":"Phenotype and functional changes of Vgamma9\/Vdelta2 T lymphocytes in Beh\u00e7et's disease and the effect of infliximab on Vgamma9\/Vdelta2 T cell expansion, activation and cytotoxicity","volume":"12","author":"Accardo-Palumbo","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.12.006_bb0565","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/08820538.2011.588665","article-title":"The use of biologic agents in the treatment of ocular manifestations of Beh\u00e7et's disease","volume":"26","author":"Benitah","year":"2011","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.autrev.2017.12.006_bb0570","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/039463200902200235","article-title":"Safety and efficacy of etanercept in children with juvenile-onset Beh\u00e7et's disease","volume":"22","author":"Cantarini","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.autrev.2017.12.006_bb8300","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et's syndrome","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.autrev.2017.12.006_bb201804200503462504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaut.2017.05.002","article-title":"Ustekinumab for Beh\u00e7et's disease","volume":"82","author":"Mirouse","year":"2017","journal-title":"J Autoimmun."}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721830079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721830079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T12:38:38Z","timestamp":1571056718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721830079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":116,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S156899721830079X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.12.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beh\u00e7et's disease: New insights into pathophysiology, clinical features and treatment options","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}